APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perfluorocarbon-based Ultrasound Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Perfluorocarbon-based Ultrasound Contrast Agents Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchPerfluorocarbon-based Ultrasound Contrast Agents Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Perfluorocarbon-based Ultrasound Contrast Agents Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Perfluorocarbon-based Ultrasound Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Perfluorocarbon-based Ultrasound Contrast Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Perfluorocarbon-based Ultrasound Contrast Agents market include Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Feiruida Medical, Fuman Group, Lizhuo Pharmaceutical and Qi-hui Biopharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Perfluorocarbon-based Ultrasound Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Perfluorocarbon-based Ultrasound Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Perfluorocarbon-based Ultrasound Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Perfluorocarbon-based Ultrasound Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Company

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Feiruida Medical

Fuman Group

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type

Perfluorobutane

Perfluoropropane

Sulfur Hexafluoride

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application

Liver Ultrasonography

Cardiac Ultrasonography

Angiographic Ultrasonography

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Perfluorocarbon-based Ultrasound Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Perfluorocarbon-based Ultrasound Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Perfluorocarbon-based Ultrasound Contrast Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Perfluorocarbon-based Ultrasound Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perfluorocarbon-based Ultrasound Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perfluorocarbon-based Ultrasound Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perfluorocarbon-based Ultrasound Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perfluorocarbon-based Ultrasound Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Perfluorocarbon-based Ultrasound Contrast Agents industry.

Chapter 3: Detailed analysis of Perfluorocarbon-based Ultrasound Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Perfluorocarbon-based Ultrasound Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Perfluorocarbon-based Ultrasound Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends Table 2. Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers Table 3. Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges Table 4. Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints Table 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Company (2021-2026) Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Company (Units) & (2021-2026) Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Company (2021-2026) Table 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Key Company Manufacturing Base & Headquarters Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Company, Product Type & Application Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Perfluorobutane Table 18. Significant Companies of Perfluoropropane Table 19. Significant Companies of Sulfur Hexafluoride Table 20. Significant Companies of Others Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type (2021-2026) & (Units) Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type (2027-2032) & (Units) Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Type (2021-2026) Table 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Type (2027-2032) Table 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type (2021-2026) Table 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Liver Ultrasonography Table 32. Significant Companies of Cardiac Ultrasonography Table 33. Significant Companies of Angiographic Ultrasonography Table 34. Significant Companies of Others Table 35. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application (2021-2026) & (Units) Table 37. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application (2027-2032) & (Units) Table 38. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Application (2021-2026) Table 39. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Application (2027-2032) Table 40. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application (2021-2026) Table 44. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application (2027-2032) Table 45. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026) & (Units) Table 47. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2026) Table 48. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2027-2032) & (Units) Table 49. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2027-2032) Table 50. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Region (2021-2026) Table 53. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Region (2027-2032) Table 55. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 60. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2026) Table 61. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 62. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2027-2032) Table 63. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Market Share by Country (2021-2026) Table 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Market Share by Country (2027-2032) Table 67. Bracco Company Information Table 68. Bracco Business Overview Table 69. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 71. Bracco Recent Development Table 72. GE Healthcare Company Information Table 73. GE Healthcare Business Overview Table 74. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 76. GE Healthcare Recent Development Table 77. ImaRx Therapeutics Company Information Table 78. ImaRx Therapeutics Business Overview Table 79. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 81. ImaRx Therapeutics Recent Development Table 82. Lantheus Medical Imaging Company Information Table 83. Lantheus Medical Imaging Business Overview Table 84. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 86. Lantheus Medical Imaging Recent Development Table 87. Microvascular Therapeutics Company Information Table 88. Microvascular Therapeutics Business Overview Table 89. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 91. Microvascular Therapeutics Recent Development Table 92. Feiruida Medical Company Information Table 93. Feiruida Medical Business Overview Table 94. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 96. Feiruida Medical Recent Development Table 97. Fuman Group Company Information Table 98. Fuman Group Business Overview Table 99. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 101. Fuman Group Recent Development Table 102. Lizhuo Pharmaceutical Company Information Table 103. Lizhuo Pharmaceutical Business Overview Table 104. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 106. Lizhuo Pharmaceutical Recent Development Table 107. Qi-hui Biopharmaceutical Company Information Table 108. Qi-hui Biopharmaceutical Business Overview Table 109. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 111. Qi-hui Biopharmaceutical Recent Development Table 112. SUNΛ Med-Engineering Company Information Table 113. SUNΛ Med-Engineering Business Overview Table 114. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 116. SUNΛ Med-Engineering Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List Table 120. Perfluorocarbon-based Ultrasound Contrast Agents Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Product Image Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2021-2032) & (Units) Figure 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Perfluorobutane Image Figure 10. Perfluoropropane Image Figure 11. Sulfur Hexafluoride Image Figure 12. Others Image Figure 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Type (2021-2032) Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type (2021-2032) Figure 19. Liver Ultrasonography Image Figure 20. Cardiac Ultrasonography Image Figure 21. Angiographic Ultrasonography Image Figure 22. Others Image Figure 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Application (2021-2032) Figure 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application (2021-2032) Figure 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 34. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 40. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Perfluorocarbon-based Ultrasound Contrast Agents Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorobutane
  • Perfluoropropane
  • Sulfur Hexafluoride
  • Others
Applications
  • Liver Ultrasonography
  • Cardiac Ultrasonography
  • Angiographic Ultrasonography
  • Others
Companies covered
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Feiruida Medical
  • Fuman Group
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  4. 1.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
  1. 2.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends
  2. 2.2 Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers
  3. 2.3 Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints
3 Perfluorocarbon-based Ultrasound Contrast Agents Market by Company
  1. 3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Company Revenue Ranking in 2025
  2. 3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (2021-2026)
  3. 3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Company (2021-2026)
  5. 3.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Company Ranking (2024-2026)
  6. 3.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Company Product Type and Application
  8. 3.8 Global Perfluorocarbon-based Ultrasound Contrast Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Perfluorocarbon-based Ultrasound Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Perfluorocarbon-based Ultrasound Contrast Agents Market by Type
  1. 4.1 Perfluorocarbon-based Ultrasound Contrast Agents Type Introduction
  2. 4.1.1 Perfluorobutane
  3. 4.1.2 Perfluoropropane
  4. 4.1.3 Sulfur Hexafluoride
  5. 4.1.4 Others
  6. 4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type
  7. 4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type
  11. 4.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Type (2021-2032)
  13. 4.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type (2021-2032)
5 Perfluorocarbon-based Ultrasound Contrast Agents Market by Application
  1. 5.1 Perfluorocarbon-based Ultrasound Contrast Agents Application Introduction
  2. 5.1.1 Liver Ultrasonography
  3. 5.1.2 Cardiac Ultrasonography
  4. 5.1.3 Angiographic Ultrasonography
  5. 5.1.4 Others
  6. 5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application
  7. 5.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application
  11. 5.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Application (2021-2032)
  13. 5.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application (2021-2032)
6 Perfluorocarbon-based Ultrasound Contrast Agents Regional Sales and Value Analysis
  1. 6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2027-2032)
  5. 6.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  12. 6.6.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  21. 6.9.2 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Country, 2025 VS 2032
7 Perfluorocarbon-based Ultrasound Contrast Agents Country-level Sales and Value Analysis
  1. 7.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032)
  6. 7.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco
  2. 8.1.1 Bracco Company Information
  3. 8.1.2 Bracco Business Overview
  4. 8.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  6. 8.1.5 Bracco Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 ImaRx Therapeutics
  14. 8.3.1 ImaRx Therapeutics Company Information
  15. 8.3.2 ImaRx Therapeutics Business Overview
  16. 8.3.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  18. 8.3.5 ImaRx Therapeutics Recent Developments
  19. 8.4 Lantheus Medical Imaging
  20. 8.4.1 Lantheus Medical Imaging Company Information
  21. 8.4.2 Lantheus Medical Imaging Business Overview
  22. 8.4.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  24. 8.4.5 Lantheus Medical Imaging Recent Developments
  25. 8.5 Microvascular Therapeutics
  26. 8.5.1 Microvascular Therapeutics Company Information
  27. 8.5.2 Microvascular Therapeutics Business Overview
  28. 8.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  30. 8.5.5 Microvascular Therapeutics Recent Developments
  31. 8.6 Feiruida Medical
  32. 8.6.1 Feiruida Medical Company Information
  33. 8.6.2 Feiruida Medical Business Overview
  34. 8.6.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  36. 8.6.5 Feiruida Medical Recent Developments
  37. 8.7 Fuman Group
  38. 8.7.1 Fuman Group Company Information
  39. 8.7.2 Fuman Group Business Overview
  40. 8.7.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  42. 8.7.5 Fuman Group Recent Developments
  43. 8.8 Lizhuo Pharmaceutical
  44. 8.8.1 Lizhuo Pharmaceutical Company Information
  45. 8.8.2 Lizhuo Pharmaceutical Business Overview
  46. 8.8.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  48. 8.8.5 Lizhuo Pharmaceutical Recent Developments
  49. 8.9 Qi-hui Biopharmaceutical
  50. 8.9.1 Qi-hui Biopharmaceutical Company Information
  51. 8.9.2 Qi-hui Biopharmaceutical Business Overview
  52. 8.9.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  54. 8.9.5 Qi-hui Biopharmaceutical Recent Developments
  55. 8.10 SUNΛ Med-Engineering
  56. 8.10.1 SUNΛ Med-Engineering Company Information
  57. 8.10.2 SUNΛ Med-Engineering Business Overview
  58. 8.10.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  60. 8.10.5 SUNΛ Med-Engineering Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Analysis
  2. 9.1.1 Perfluorocarbon-based Ultrasound Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Perfluorocarbon-based Ultrasound Contrast Agents Sales Mode & Process
  6. 9.2 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
  9. 9.2.3 Perfluorocarbon-based Ultrasound Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst